Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway

European Journal of Endocrinology

Volumn 169, Issue 6, 2013, Pages 845-852

  Svare, Anders ^a,b   Nilsen, Tom Ivar Lund ^c   Åsvold, Bjørn Olav ^a,d   Forsmo, Siri ^a   Schei, Berit ^a   Bjøro, Trine ^e,f   Langhammer, Arnulf ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Namsos Hospital   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; FOREARM FRACTURE; HEALTH SURVEY; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; SELF REPORT; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST; BLOOD; BONE DENSITY; FRACTURES, BONE; HIP FRACTURES; INCIDENCE; METABOLISM; MIDDLE AGED; RADIUS FRACTURES; RISK; THYROID GLAND; ULNA FRACTURES;

ADULT; AGED; BONE DENSITY; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HIP FRACTURES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NORWAY; ODDS RATIO; PROSPECTIVE STUDIES; RADIUS FRACTURES; REGISTRIES; RISK; THYROID FUNCTION TESTS; THYROID GLAND; THYROTROPIN; ULNA FRACTURES;

EID: 84888211682     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0546     Document Type: Article

References (38)

1. Bjøro T, Holmen J, Kruger O, Midthjell K, Hunstad K, Schreiner T, Sandnes L & Brochmann H. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). European Journal of Endocrinology 2000 143 639-647. (doi:10.1530/eje.0.1430639)
2. Boelaert K & Franklyn JA. Thyroid hormone in health and disease. Journal of Endocrinology 2005 187 1-15. (doi:10.1677/joe.1. 06131)
3. Cooper DS & Biondi B. Subclinical thyroid disease. Lancet 2012 379 1142-1154. (doi:10.1016/S0140-6736 (11) 60276-6)
4. Barrett-Connor E, Weiss TW, McHorney CA, Miller PD & Siris ES. Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporosis International 2009 20 715-722. (doi:10.1007/s00198-008-0748-2)
5. von Recklinghausen FD. Die fibröse oder deformierende Ostitis, die Osteomalazie und die osteoplastische Karzinose in ihren gegenseitigen Beziehungen. Festschrift R. Virchow, pp 1-89. Berlin: Georg Reimer Verlag, 1891.
6. Ahmed LA, Schirmer H, Berntsen GK, Fonnebo V & Joakimsen RM. Self-reported diseases and the risk of non-vertebral fractures: the Tromso study. Osteoporosis International 2006 17 46-53. (doi:10.1007/s00198-005-1892-6)
7. Bauer DC, Ettinger B, Nevitt MC & Stone KL. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Annals of Internal Medicine 2001 134 561-568. (doi:10.7326/0003-4819-134-7-200104030-00009)
8. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D & Vogt TM. Risk factors for hip fracture in white women. New England Journal of Medicine 1995 332 767-773. (doi:10.1056/NEJM199503 233321202)
9. Gallagher JC, Melton LJ & Riggs BL. Examination of prevalence rates of possible risk factors in a population with a fracture of the proximal femur. Clinical Orthopaedics and Related Research 1980 153 158-165.
10. Vestergaard P, Weeke J, Hoeck HC, Nielsen HK, Rungby J, Rejnmark L, Laurberg P & Mosekilde L. Fractures in patients with primary idiopathic hypothyroidism. Thyroid 2000 10 335-340. (doi:10.1089/thy.2000.10.335)
11. Vestergaard P, Rejnmark L, Weeke J & Mosekilde L. Fracture risk in patients treated for hyperthyroidism. Thyroid 2000 10 341-348. (doi:10.1089/thy.2000.10.341)
12. Vestergaard P, Rejnmark L & Mosekilde L. Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcified Tissue International 2005 77 139-144. (doi:10.1007/s00223-005-0068-x)
13. Waring AC, Harrison S, Fink HA, Samuels MH, Cawthon PM, Zmuda JM, Orwoll ES & Bauer DC. A prospective study of thyroid function, bone loss, and fractures in older men: the MrOS study. Journal of Bone and Mineral Research 2013 28 472-479. (doi:10.1002/jbmr.1774)
14. Wejda B, Hintze G, Katschinski B, Olbricht T & Benker G. Hip fractures and the thyroid: a case-control study. Journal of Internal Medicine 1995 237 241-247. (doi:10.1111/j.1365-2796.1995. tb01172.x)
15. Lee JS, Buzkova P, Fink HA, Vu J, Carbone L, Chen Z, Cauley J, Bauer DC, Cappola AR & Robbins J. Subclinical thyroid dysfunction and incident hip fracture in older adults. Archives of Internal Medicine 2010 170 1876-1883. (doi:10.1001/archinternmed. 2010.424)
16. Vadiveloo T, Donnan PT, Cochrane L & Leese GP. The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 2011 96 1344-1351. (doi:10.1210/jc.2010-2693)
17. Mazziotti G, Porcelli T, Patelli I, Vescovi PP & Giustina A. Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. Bone 2010 46 747-751. (doi:10.1016/j.bone.2009. 10.031)
18. Murphy E, Gluer CC, Reid DM, Felsenberg D, Roux C, Eastell R & Williams GR. Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2010 95 3173-3181. (doi:10.1210/jc.2009-2630)
19. Seeley DG, Kelsey J, Jergas M & Nevitt MC. Predictors of ankle and foot fractures in older women. The Study of Osteoporotic Fractures Research Group. Journal of Bone and Mineral Research 1996 11 1347-1355. (doi:10.1002/jbmr. 5650110920)
20. 4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clinical Endocrinology 2008 68 75-81. (doi:10.1111/j.1365-2265.2007.03016.x)
21. Belsing TZ, Tofteng C, Langdahl BL, Charles P & Feldt-Rasmussen U. Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease? Nutrition & Metabolism 2010 7 72. (doi:10.1186/1743- 7075-7-72)
22. Majima T, Komatsu Y, Doi K, Takagi C, Shigemoto M, Fukao A, Morimoto T, Corners J & Nakao K. Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease. Osteoporosis International 2006 17 1103-1110. (doi:10.1007/s00198-006-0091-4)
23. Holmen J, Midthjell K, Krüger Ø, Langhammer A, Holmen TL, Bratberg GH, Vatten L & Lund-Larsen PG. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents and participation. Norsk Epidemiologi 2003 13 19-32.
24. Surks MI, Goswami G & Daniels GH. The thyrotropin reference range should remain unchanged. Journal of Clinical Endocrinology and Metabolism 2005 90 5489-5496. (doi:10.1210/jc.2005-0170)
25. Diez JJ & Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. Journal of Clinical Endocrinology and Metabolism 2004 89 4890-4897. (doi:10.1210/jc.2003-032061)
26. Parle JV, Franklyn JA, Cross KW, Jones SC & Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clinical Endocrinology 1991 34 77-83. (doi:10.1111/j.1365- 2265.1991. tb01739.x)
27. Diamantopoulos AP, Rohde G, Johnsrud I, Skoie IM, Hochberg M & Haugeberg G. The epidemiology of low- and high-energy distal radius fracture in middle-aged and elderly men and women in Southern Norway. PLoS ONE 2012 7 e43367. (doi:10.1371/journal.pone.0043367)
28. Rothman KJ, Greenland S & Lash TL. Validity in epidemiologic studies. In Modern Epidemiology, 3rd edn, ch 9, pp 128-147. Eds Rothman KJ, Greenland S & Lash TL. Philadelphia: Lippincott Williams & Wilkins, 2008.
29. El Hadidy el HM, Ghonaim M, El Gawad SS & El Atta MA. Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men. BMC Endocrine Disorders 2011 11 15. (doi:10.1186/1472-6823-11-15)
30. Udayakumar N, Chandrasekaran M, Rasheed MH, Suresh RV & Sivaprakash S. Evaluation of bone mineral density in thyrotoxicosis. Singapore Medical Journal 2006 47 947-950.
31. Svare A, Nilsen TI, Bjoro T, Forsmo S, Schei B & Langhammer A. Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study. European Journal of Endocrinology 2009 161 779-786. (doi:10.1530/EJE-09- 0139)
32. Kim BJ, Lee SH, Bae SJ, Kim HK, Choe JW, Kim HY, Koh JM & Kim GS. The association between serum thyrotropin (TSH) levels and bone mineral density in healthy euthyroid men. Clinical Endocrinology 2010 73 396-403. (doi:10.1111/j.1365-2265. 2010.03818.x)
33. Kim DJ, Khang YH, Koh JM, Shong YK & Kim GS. Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women. Clinical Endocrinology 2006 64 86-90. (doi:10.1111/j.1365-2265.2005.02422.x)
34. Morris MS. The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women. Bone 2007 40 1128-1134. (doi:10.1016/j. bone.2006.12.001)
35. Grimnes G, Emaus N, Joakimsen RM, Figenschau Y & Jorde R. The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromso study. Thyroid 2008 18 1147-1155. (doi:10.1089/thy.2008.0158)
36. Lee WY, Oh KW, Rhee EJ, Jung CH, Kim SW, Yun EJ, Tae HJ, Baek KH, Kang MI, Choi MG et al. Relationship between subclinical thyroid dysfunction and femoral neck bone mineral density in women. Archives of Medical Research 2006 37 511-516. (doi:10.1016/j.arcmed.2005.09.009)
37. Oksanen T, Kivimaki M, Pentti J, Virtanen M, Klaukka T & Vahtera J. Self-report as an indicator of incident disease. Annals of Epidemiology 2010 20 547-554. (doi:10.1016/j.annepidem. 2010.03.017)
38. Surks MI & Ocampo E. Subclinical thyroid disease. American Journal of Medicine 1996 100 217-223. (doi:10.1016/S0002-9343 (97) 89462-4)